Arcato Laboratories, Inc. (https://www.arcato-labs.com/) today simultaneously announced successful top line results from its first-in-human Phase 1 study of ARC-001 Gel in patients following third molar (wisdom tooth) extraction surgery, as well as the closing of its first round of financing.
